You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

orally administered

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leishmaniasis Trial in Tübingen (Oleylphosphocholine)

Recruiting
  • Leishmaniasis
  • Tübingen, Germany
    Institute for Tropical Medicine
Nov 8, 2023

Safety and Tolerability Trial in Shanghai (JMKX003002 will be administered orally, Placebo in Cohorts 1 to 5, Placebo in 2

Recruiting
  • Safety and Tolerability
  • JMKX003002 will be administered orally
  • +2 more
  • Shanghai, Shanghai, China
    Huashan Hospital Fudan University
Jun 15, 2023

Safety and Tolerability Trial in Shanghai (JMKX003142 will be administered orally, Placebo in Cohorts 1 to 7, Placebo in 3

Recruiting
  • Safety and Tolerability
  • JMKX003142 will be administered orally
  • +2 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Oct 13, 2023

Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and

Recruiting
  • Bioequivalence
  • Schizophrenia
  • Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023

MDD (MDD Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg, Vortioxetine Hemihydrobromide

Active, not recruiting
  • Major Depressive Disorder (MDD
  • Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg
  • +2 more
  • Ahmedabad, Gujarat, India
    Cliantha Research Limited
Oct 24, 2022

Healthy Trial in Christchurch (LTG-001, Placebo)

Not yet recruiting
  • Healthy
  • Christchurch, New Zealand
    Clinical Research Unit
Sep 21, 2023

Healthy Volunteers Trial in Melbourne (Stelara, RT-111 (0.5mg), RT-111 (0.75mg))

Not yet recruiting
  • Healthy Volunteers
  • Melbourne, Australia
    Nucleus Network
Jun 5, 2023

Memory Dysfunction, Anxiety, Depression Trial in Zarqa (Thymus vulgaris)

Completed
  • Memory Dysfunction
  • +3 more
  • Thymus vulgaris
  • Zarqa, Jordan
    Faculty of Pharmaceutical Sciences
Aug 9, 2023

Phenylketonuria Trial (CBT102-A capsule, Placebo capsule)

Not yet recruiting
  • Phenylketonuria
  • CBT102-A capsule
  • Placebo capsule
  • (no location specified)
Jul 9, 2023

MDD (MDD) Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets)

Active, not recruiting
  • Major Depressive Disorder (MDD)
  • Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
  • Ahmedabad, Gujarat, India
    Cliantha Research Limited
Oct 24, 2022

MDD (MDD) Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets, Vortioxetine Hydrobromide Tablets)

Active, not recruiting
  • Major Depressive Disorder (MDD)
  • Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
  • Vortioxetine Hydrobromide Tablets
  • Ahmedabad, Gujarat, India
    Cliantha Research Limited
Nov 3, 2022

Periodontitis, Probiotics, Non Surgical Periodontal Therapy Trial in Chieti (Experimental, Negative control, Positive control)

Not yet recruiting
  • Periodontitis
  • +2 more
  • Experimental
  • +2 more
  • Chieti, Italy
    University G. d'Annunzio
Sep 30, 2023

COVID-19, SARS CoV 2 Infection Trial (Prolectin-M)

Not yet recruiting
  • COVID-19
  • SARS CoV 2 Infection
  • (no location specified)
Feb 8, 2023

Induced Vaginal Delivery Trial in Stockholm (Misoprostol)

Recruiting
  • Induced Vaginal Delivery
  • Stockholm, Sweden
    Södersjukhuset
Jun 15, 2022

Lupus Nephritis Trial in Alexandria (Dapagliflozin 10mg Tab orally once daily)

Not yet recruiting
  • Lupus Nephritis
  • Dapagliflozin 10mg Tab orally once daily
  • Alexandria, Egypt
    Ain Shams University
Oct 27, 2023

Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria Trial (ZY19489 + Ferroquine (FQ), Placebo)

Not yet recruiting
  • Uncomplicated Malaria
  • +2 more
  • ZY19489 + Ferroquine (FQ)
  • Placebo
  • (no location specified)
Jun 18, 2023

COVID-19 Trial in Jinan (QLS1128, Placebo)

Recruiting
  • COVID-19
  • Jinan, Shandong, China
    Qilu Pharmaceutical Co., Ltd.
Jan 15, 2023

Abuse Potential Trial in Overland Park (Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg)

Completed
  • Abuse Potential
  • Placebo
  • +4 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas
Oct 19, 2023

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,

Completed
  • Smallpox
  • +3 more
  • NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
  • +5 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023

Whipworm, Trichuriasis, Controlled Human Infection Trial in Washington, Bethesda (Trichuris trichiura Egg Inoculum)

Not yet recruiting
  • Whipworm
  • +2 more
  • Trichuris trichiura Egg Inoculum
  • Washington, District of Columbia
  • +1 more
Jan 20, 2023

Healthy Volunteers Trial in Salt Lake City (DC-806, Itraconazole, Carbamazepine)

Recruiting
  • Healthy Volunteers
  • Salt Lake City, Utah
    ICON Phase I Clinic
Aug 9, 2023

Sickle Cell Disease Trial in Vadodara, Nagpur, Pune (NUV001 - IR, NUV001 - GR, Placebo)

Not yet recruiting
  • Sickle Cell Disease
  • NUV001 - IR
  • +2 more
  • Vadodara, Gujarat, India
  • +2 more
Mar 17, 2023

Lianhua Qingwen in Treating Patients Infected With Omicron

Not yet recruiting
  • COVID-19 Pneumonia
  • The group of patients who received Lianhua Qingwen orally
  • The group of patients who did not receive Lianhua Qingwen orally
  • (no location specified)
Mar 20, 2023

Orally Administered Metoprolol on Frequency and Severity of

Completed
  • Pain
  • Rocuronium injection pain
  • (no location specified)
Jul 11, 2022

Sarcopenia Trial in Orlando (BPM31510, Placebo)

Not yet recruiting
  • Sarcopenia
  • Orlando, Florida
    AdventHealth Translational Research Institute
Aug 2, 2022